Хирургическое лечение свищевой формы болезни Крона с пластикой передней брюшной стенки(Клиническое наблюдение)
Аннотация
Об авторах
Ю. Е. КиценкоРоссия
О. С. Шифрин
Россия
П. В. Царьков
Россия
Список литературы
1. Louis E. Epidemiology of the transition from early to late Crohn’s disease. Dig Dis 2012;30(4):376-9.
2. Shaffer V.O., Wexner S.D. Surgical management of Crohn’s disease. Langenbecks Arch Surg 2013;398(1):1327.
3. Савельев В.С., Кириенко А.И. Клиническая хирургия: Национальное руководство. В 3 т: т. 2. М.: ГЭОТАРМедиа; 2009.
4. AbdullGaffar B. Granulomatous diseases and granulomas of the appendix. Int J Surg Pathol 2010;18(1):14-20.
5. Tabry H., Farrands P.A. Update on anal fistulae: surgical perspectives for the gastroenterologist. Can J Gastroenterol 2011;25(12):675-80.
6. Weisshof R., Ungar B., Blatt A., Dahan A., Pressman S., Waterman M., Kopylov U., BenHorin S., Chowers Y. Anti-infliximab antibodies with neutralizing capacity in patients with inflammatory bowel disease: Distinct clinical implications revealed by a novel assay. Inflamm Bowel Dis 2016.
7. Ananthakrishnan A.N., Cagan A., Cai T., Gainer V.S., Shaw S.Y., Savova G., Churchill S., Karlson E.W., Kohane I., Liao K.P., Murphy S.N. Comparative effectiveness of Infliximab and Adalimumab in Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis 2016;22(4):880-5.
8. Onali S., Calabrese E., Petruzziello C., Lolli E., Ascolani M., Ruffa A., Sica G., Rossi A., Chiaramonte C., Pallone F., Biancone L. Post-operative recurrence of Crohn’s disease: A prospective study at 5 years. Dig Liver Dis 2016;48(5):489-94.
9. Schwartz D.A., Loftus E.V., Jr., Tremaine W.J., Panaccione R., Harmsen W.S., Zinsmeister A.R., Sandborn W.J. The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology 2002;122(4):875-80.
10. West R.L., van der Woude C.J., Endtz H.P., Hansen B.E., Ouwedijk M., Boelens H.A., Kusters J.G., Kuipers E.J. Perianal fistulas in Crohn’s disease are predominantly colonized by skin flora: implications for antibiotic treatment? Dig Dis Sci 2005;50(7):1260-3.
11. Tannoury J., Abboud B. Treatment options of inflammatory appendiceal masses in adults. World J Gastroenterol 2013;19(25):3942-50.
12. Bass J.A., Goldman J., Jackson M.A., Gasior A.C., Sharp S.W., Drews A.A., Saunders C.J., St Peter S.D. Pediatric Crohn’s disease presenting as appendicitis: differentiating features from typical appendicitis. Eur J Pediatr Surg 2012;22(4):274-8.
13. Sands B.E., Anderson F.H., Bernstein C.N., Chey W.Y., Feagan B.G., Fedorak R.N., Kamm M.A., Korzenik J.R., Lashner B.A., Onken J.E., Rachmilewitz D., Rutgeerts P., Wild G., Wolf D.C., Marsters P.A., Travers S.B., Blank M.A., van Deventer S.J. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med 2004;350(9):87685.
14. Bor R., Farkas K., Balint A., Szucs M., Abraham S., Baradnay G., Wittmann T., Szepes Z., Nagy F., Molnar T. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn’s disease clinical observations from a tertiary Eastern European center. Scand J Gastroenterol 2015;50(2):182-7.
15. Amiot A., Setakhr V., Seksik P., Allez M., Treton X., de Vos M., Laharie D., Colombel J.F., Abitbol V., Reimund J.M., Moreau J., Veyrac M., Flourie B., Cosnes J., Lemann M., Bouhnik Y. Long-term outcome of enterocutaneous fistula in patients with Crohn’s disease treated with anti-TNF therapy: a cohort study from the GETAID. Am J Gastroenterol 2014;109(9):1443-9.
16. Gecse K., Khanna R., Stoker J., Jenkins J.T., Gabe S., Hahnloser D., D’Haens G. Fistulizing Crohn’s disease: Diagnosis and management. United Eur Gastroenterol J 2013;1(3):206-13.
17. Nielsen O.H., Rogler G., Hahnloser D., Thomsen O.O. Diagnosis and management of fistulizing Crohn’s disease. Nat Clin Pract Gastroenterol Hepatol 2009;6(2):92-106.
18. Hansen R.A., Gartlehner G., Powell G.E., Sandler R.S. Serious adverse events with infliximab: analysis of spontaneously reported adverse events. Clin Gastroenterol Hepatol 2007;5(6):729-35.
19. Myrelid P., MartiGallostra M., Ashraf S., Sunde M.L., Tholin M., Oresland T., Lovegrove R.E., Tottrup A., Kjaer D.W., George B.D. Complications in surgery for Crohn’s disease after preoperative antitumour necrosis factor therapy. Br J Surg 2014;101(5):539-45.
20. Rosenfeld G., Qian H., Bressler B. The risks of postoperative complications following pre-operative infliximab therapy for Crohn’s disease in patients undergoing abdominal surgery: a systematic review and meta-analysis. J Crohns Colitis 2013;7(11):868-77.
21. Varma P., Paul E., Huang C., Headon B., Sparrow M.P. A retrospective comparison of infliximab versus adalimumab as induction and maintenance therapy for Crohn disease. Int Med J 2016;46(7):798-804.
Для цитирования:
Киценко Ю.Е., Шифрин О.С., Царьков П.В. Хирургическое лечение свищевой формы болезни Крона с пластикой передней брюшной стенки(Клиническое наблюдение). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2017;27(3):93-100. https://doi.org/10.22416/1382-4376-2017-27-3-93-100
For citation:
Kitsenko Yu.Y., Shifrin O.S., Tsarkov P.V. Surgical treatment of the fistulizing Crohn's disease with anterior abdominal wall reconstruction (Clinical case). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(3):93-100. (In Russ.) https://doi.org/10.22416/1382-4376-2017-27-3-93-100

Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.